These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33455917)

  • 21. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
    Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K
    Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporin for treatment of refractory multisystemic inflammatory syndrome in a child.
    Gámez-González LB; Hamada H; Yamazaki-Nakashimada MA
    Cardiol Young; 2023 May; 33(5):800-802. PubMed ID: 36052505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking.
    Xu XR; Zhang W; Wu XX; Yang HQ; Sun YT; Pu YT; Wang B; Peng W; Sun LH; Guo Q; Zhou S; Fang BJ
    J Integr Med; 2022 Nov; 20(6):561-574. PubMed ID: 35934629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal effects of cyclosporine.
    Bennett WM
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1280-5; discussion 1285-7. PubMed ID: 2277136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact on energy metabolism of quantitative and functional cyclosporine-induced damage of kidney mitochondria.
    Aupetit B; Ghazi A; Blanchouin N; Toury R; Shechter E; Legrand JC
    Biochim Biophys Acta; 1988 Dec; 936(3):325-31. PubMed ID: 2848579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hope and Resilience Related to Fear of COVID-19 in Young People.
    Javier-Aliaga DJ; Quispe G; Quinteros-Zuñiga D; Adriano-Rengifo CE; White M
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome.
    Moawad P; Shamma R; Hassanein D; Ragab G; El Zawahry O
    Eur J Ophthalmol; 2022 Jan; 32(1):673-679. PubMed ID: 33530719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronavirus anxiety, fear of COVID-19, hope and resilience in healthcare workers: a moderated mediation model study.
    Yıldırım M; Güler A
    Health Psychol Rep; 2021; 9(4):338-397. PubMed ID: 38084306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topical cyclosporine in ophthalmology: Pharmacology and clinical indications].
    Levy O; Labbé A; Borderie V; Laroche L; Bouheraoua N
    J Fr Ophtalmol; 2016 Mar; 39(3):292-307. PubMed ID: 26997607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mediating role of hope in relation with fear of COVID-19 and mental health: A study on tertiary level students of Rajshahi District.
    Sarker PC; Sugawara D; Nishad MFR
    Health Sci Rep; 2022 Sep; 5(5):e836. PubMed ID: 36189409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fear of COVID-19 and Anxiety: Serial Mediation by Trust in the Government and Hope.
    Yang Y; Wang H
    Psychol Res Behav Manag; 2023; 16():963-970. PubMed ID: 36998742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe Generalized Bullous Fixed Drug Eruption Treated with Cyclosporine: A Case Report and Literature Review.
    Barootes HC; Peebles ER; Matsui D; Rieder M; Abuzgaia A; Mohammed JA
    Case Rep Dermatol; 2021; 13(1):154-163. PubMed ID: 33790760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine in the Treatment of Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: Retrospective Cohort Study.
    Zita S; Broussard L; Hugh J; Newman S
    JMIR Dermatol; 2023 Jul; 6():e41391. PubMed ID: 37632913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease.
    Li C; Zhou X; Zhong Y; Li C; Dong A; He Z; Zhang S; Wang B
    J Immunol; 2016 Feb; 196(4):1721-31. PubMed ID: 26792805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe autoimmune hemolytic anemia complicating hereditary spherocytosis treated successfully with glucocorticoids and cyclosporine: a case report.
    Wang N; Lu H; Li L; Gong M; Cao Y
    Hematology; 2023 Dec; 28(1):2235832. PubMed ID: 37504499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hope During COVID-19 Lockdown.
    Redlich Amirav D; Besor O; Amirav I
    Cureus; 2021 May; 13(5):e15097. PubMed ID: 34159006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking.
    Ruan X; Du P; Zhao K; Huang J; Xia H; Dai D; Huang S; Cui X; Liu L; Zhang J
    Chin Med; 2020; 15():62. PubMed ID: 32536965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine in dermatology: pharmacology and clinical use.
    Kauvar AB; Stiller MJ
    Int J Dermatol; 1994 Feb; 33(2):86-96. PubMed ID: 8157407
    [No Abstract]   [Full Text] [Related]  

  • 39. Examining the longitudinal effects and potential mechanisms of hope on COVID-19 stress, anxiety, and well-being.
    Gallagher MW; Smith LJ; Richardson AL; D'Souza JM; Long LJ
    Cogn Behav Ther; 2021 May; 50(3):234-245. PubMed ID: 33544032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular Therapy: The Hope for Covid-19.
    Nobari S; Rezvan M; Dashtestani F; Gangi M; Keshmiri Neghab H
    Avicenna J Med Biotechnol; 2022; 14(2):104-113. PubMed ID: 35633981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.